Research ethics for emerging trial designs: does equipoise need to adapt?
BMJ
.
2018 Jan 25:360:k226.
doi: 10.1136/bmj.k226.
Authors
Spencer Phillips Hey
1
2
,
Charles Weijer
3
,
Monica Taljaard
4
,
Aaron S Kesselheim
5
2
Affiliations
1
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, USA shey@bwh.harvard.edu.
2
Center for Bioethics, Harvard Medical School, Boston, USA.
3
Rotman Institute of Philosophy, Western University, London, Canada.
4
Clinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa, Canada.
5
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
PMID:
29371211
DOI:
10.1136/bmj.k226
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic / ethics*
Clinical Trials as Topic / methods
Ethics, Research
Research Design*
Therapeutic Equipoise*